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Angiogenesis gained a stable position in the field of patho-
genesis.Vascularchangesarearecognizedhallmarkofcancer
growth,inflammatorydisorders,andretinadisorders,partic-
ularly in the context of diabetes. The inflammatory process,
defined by the release of mediators from activated neutro-
phils, macrophages, and other myeloid cells, intersects with
vascular changes, but the nature of this interrelationship fre-
quentlyremainscomplexandpuzzling,andtheconsequences
remain difficult to predict. Clearly, a better understanding
of molecular and cellular pathways that link angiogenesis
and inflammation would be helpful in the development
oftreatmentofconditionswherebothprocessesareinvolved.
Although many of these mediators involved in angiogenesis
are well known, there is still a need for further clarification of
their activity.
This special issue contains eight independent articles, of
which three are focused on the pathogenesis of inadequate
angiogenesis in human disease, and two are experimental
papers using rodent models. There are three review articles
which describe both physiological aspects of angiogenesis
and its possible keys for modification.
Articles included in this special issue also reflect the
notion that angiogenesis is a fragment of the biological con-
tinuum involved in tissue development, remodeling, and
repair, including haemostasis, inflammation, and vascular
growth. These mechanisms are often subverted in patholog-
ical states, such as chronic injury, diabetes, or cancer, but
remain intimately linked. Inflammation and angiogenesis
have often been studied as separate entities; however, several
articles in this issue document the existence of important
biological linkages between them.
“Fractalkine (CX3CL1) and its receptor CX3CR1 may con-
tribute to increased angiogenesis in diabetic placenta”b yD .
Szukiewicz et al. describes how an inflammatory chemokine
known as fractalkine (CX3CL1) may act as direct modulator
of angiogenesis by virtue of interacting with its receptors
(CX3CR1) present on endothelial cells. This process is upreg-
ulated in placenta of patientswith diabetes class C, leading to
increased microvascular density. This is important as abnor-
mal remodeling of placental vasculature may impact oxygen
exchange and fetal health.
“Antiangiogenic VEGF isoform in inflammatory myop-
athies” by N. Volpi et al. shows that VEGF-A165b is signif-
icantly upregulated in idiopathic inflammatory myopathies,
as well as TGF-𝗽.V E G F - Ai sa l s os h o w nt ob ed i ff u s e l y
expressed on unaffected myofibres, whereas regenerating/
atrophic myofibres strongly react for both VEGF-A isoforms.
Mostinflammatorycellsandendomysialvesselsexpressboth
isoforms, but VEGF-A165b levels show a positive correlation
to inflammatory scores, endomysial vascularization, and
TGF-𝗽. These findings indicate that skeletal muscle expres-
sion of antiangiogenic VEGF-A165b and its preferential up-
regulation in idiopathic inflammatory myopathies suggest
that modulation of VEGF-A isoforms may occur in myosi-
tides.
“Thrombospondin and VEGF-R: is there a correlation in
inflammatoryboweldisease?”byJ.Wejmanetal.showssignif-
icantly higher vascular density and vascular area percentage
in all layers of bowel wall (not only mucosal bioptates) in
patients with Crohn’s disease (CD), which was evaluated
by immunohistochemistry analysis. This study found dif-
ferences in vascular density distribution between ulcerative
colitis (CU) and CD and between CU and controls, but
no statistically significant correlation between those find-
ings and VEGFR-1 or thrombospondin-1 (TSP-1) expression.2 Mediators of Inflammation
Overall, the results suggest the existence of different TSP-1
independent pathways of antiangiogenesis in inflammatory
bowel disease.
“Inhibitory effect of herbal remedy PERVIVO and anti-
inflammatory drugsulindaconL-1sarcoma tumorgrowthand
tumor angiogenesis in Balb/c mice”b yP .S k o p i ´ nski et al.
reveals the interesting observation concerning antiangio-
genic properties of the herbal mixture PERVIVO. The exper-
imental model was developed in Balb/c mice after grafting of
L-1sarcomacells.PERVIVOshowsantiangiogenicproperties
by decreasing de novo vessel development thereby inhibiting
tumor growth. Both effects are augmented after combining
PERVIVO with sulindac—in which a synergistic effect was
observed.
“The effect of anti-inflammatory and antimicrobial herbal
remedyPADMA28onimmunologicalangiogenesisandgranu-
locytes activity in mice” by D. M. Radomska-Le ́ sniewska et al.
wasalsofocusedontraditionalmedicinerationalizingtheuse
of herbal drugs. The in vivo stimulatory effect of PADMA 28
(which is a mixture of herbal extract) for angiogenic activity
canbemodulatedbydoseandisassociatedwithdeterioration
of granulocytes after high-dose treatment.
“Cytokines and angiogenesis in the corpus luteum”b yA .
M. Galv˜ ao describes angiogenesis in the corpus luteum as
an extremely rapid sequence of events that determines the
dramatic changes on vascular and nonvascular structures.
Themainpurposeofthisreviewistohighlighttheinteraction
between immune, endothelial, and luteal steroidogenic cells,
regarding vascular dynamics/changes during the establish-
m e n ta n dr e g r e s s i o no ft h ee q u i n ec o r p u sl u t e u m .
“Matrixmetalloproteinases:inflammatoryregulatorsofcell
behaviour in vascular formation and remodelling”b yQ .Ch e n
et al. gives the systematic review of the role of matrix met-
alloproteinases (MMP) in the process of angiogenesis. The
m a i np u r p o s eo ft h i sr e v i e wi st os h o wac o m p l e xi n t e r a c t i o n
between MMP stimulators, their mechanism of activity and
inflammatory cell recruitment.
“Angiogenesisanditstherapeuticopportunities”byS.Y .Y o
and S. M. Kwon offers a general review of angiogenesis with
a particular focus on clinical applications.
There are general implications concerning the crosstalk
between inflammatory and angiogenic circuitries. For
instance, effective ways to lower pathological angiogenesis
may require targeting not only “professional” regulators of
endothelial cell function, but also elements of the inflam-
matory network, a notion that has already been linked to
resistance of certain cancers to antiangiogenic agents. While
articles published in this special issue were not intended to
fully address these questions (the area is simply too vast),
they do draw attention to specific scenarios in which the
inflammatory-vascularcontinuumisparticularlymanifestor
functionally significant. We hope that this integrated view
will be of interest and of stimulating value to the readers.
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